Intelligent Medical Writing
Increasing R&D by pharmaceutical companies has led to a surge of demand for regulatory documents. We at DIP are dedicated to finding innovative ways to meet all aspects of these demands by bridging the expertise of writers and AI scientists to make the writing process more efficient and creative.
We help pharmaceutical companies develop AI enabled writing tools, including automatic writing, tabulated data analysis, document review, quality control, and more. Writers, coauthors, and reviewers are freed from time-consuming and repetitive tasks, allowing them to dedicate their energy and knowledge to other projects.
The timelines for regulatory documents development, such as for IND, CTA, MAA, etc., will be drastically reduced. Content quality and data accuracy will be ensured. The benefits we offer ultimately benefit the patients who are eagerly waiting for the medical innovations that can improve their lives.